Alliance gains US reprocessing clearances:
This article was originally published in Clinica
Executive Summary
Alliance Medical has received US FDA 510(k) clearances to reprocess what it says are most of the market-leading endoscopic trocars and cannulas as well as certain electrophysiology (EP) catheters and cables made by Daig. Alliance already has clearance to reprocess diagnostic EP catheters manufactured by Bard, Cordis, EP Technologies, Medtronic and Biosense Webster. Regarding the endoscopic devices, the Phoenix, Arizona firm says that an average hospital can save over $112,000 annually by reprocessing devices covered by the clcearance. As for the catheters and cables, the potential annual EP laboratory savings for reprocessing these devices is $300,000 to $1m.